Tomas Kalincik

Treatment response score to glatiramer acetate or interferon beta-1a.

Francesca Bovis, Tomas Kalincik, Fred Lublin, Gary Cutter, Charles Malpas, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Alexandre Prat, Marc Girard, Pierre Duquette, Marco Onofrj, Alessandra Lugaresi, Guillermo Izquierdo, Sara Eichau, Francesco Patti, Murat Terzi, Pierre Grammond, Roberto Bergamaschi, Patrizia Sola, et al.

Journal article  |  2020  |  Neurology

OBJECTIVE: To compare the effectiveness of glatiramer acetate (GA) vs intra-muscular Interferon beta-1a (IFNbeta-1a)), we applied ..

Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.

Nabil Seery, Vivien Li, Ai-Lan Nguyen, Izanne Roos, Katherine A Buzzard, Roberts Atvars, Nicola Taylor, Kelsey Tunnell, John Carey, Chris Dwyer, Hasini Fernandoa Lisa Taylor, Josephine Baker, Mark P Marriott, Trevor J Kilpatrick, Tomas Kalincik, Mastura Monif

Journal article  |  2020  |  Multiple Sclerosis and Related Disorders

OBJECTIVE: Patients with Multiple Sclerosis (MS) and on disease modifying therapies (DMTs) that can be immunosuppressive or immuno..

Association of Pregnancy With the Onset of Clinically Isolated Syndrome

Ai-Lan Nguyen, Karolina Vodehnalova, Tomas Kalincik, Alessio Signori, Eva Kubala Havrdova, Jeannette Lechner-Scott, Olga G Skibina, Alana Eastaugh, Lisa Taylor, Josephine Baker, Nicola McGuinn, Louise Rath, Vicki Maltby, Maria Pia Sormani, Helmut Butzkueven, Anneke van der Walt, Dana Horakova, Vilija G Jokubaitis

Journal article  |  2020  |  JAMA Neurology

Importance: Multiple sclerosis (MS) is usually diagnosed in women during their childbearing years. Currently, no consensus exists ..

Comparative effectiveness of rituximab in multiple sclerosis

Tomas Kalincik, Maria Pia Sormani

Journal article  |  2020  |  Nature Reviews Neurology

Serum microRNA is a biomarker for post-operative monitoring in glioma

Andrew Morokoff, Jordan Jones, Hong Nguyen, Chenkai Ma, Arian Lasocki, Frank Gaillard, Iwan Bennett, Rod Luwor, Stanley Stylli, Lucia Paradiso, Rachel Koldej, Iddo Paldor, Ramyar Molania, Terence P Speed, Andrew Webb, Guiseppe Infusini, Jason Li, Charles Malpas, Tomas Kalincik, Katharine Drummond, et al.

Journal article  |  2020  |  Journal of Neuro-Oncology

PURPOSE: A circulating biomarker has potential to provide more accurate information for glioma progression post treatment, however..

Delay from treatment start to full effect of immunotherapies for multiple sclerosis.

Izanne Roos, Emmanuelle Leray, Federico Frascoli, Romain Casey, J William L Brown, Dana Horakova, Eva K Havrdova, Maria Trojano, Francesco Patti, Guillermo Izquierdo, Sara Eichau, Marco Onofrj, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Grammond, Patrizia Sola, Diana Ferraro, Serkan Ozakbas, Roberto Bergamaschi, et al.

Journal article  |  2020  |  Brain

In multiple sclerosis, treatment start or switch is prompted by evidence of disease activity. Whilst immunomodulatory therapies re..

The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis

Charmaine Yam, Daniel Merlo, Jim Stankovich, David Darby, Melissa Gresle, Tomas Kalincik, Trevor J Kilpatrick, Jeanette Lechner-Scott, Bruce Taylor, Michael Barnett, Helmut Butzkueven, Anneke van der Walt

Journal article  |  2020  |  Multiple Sclerosis and Related Disorders

BACKGROUND: Monitoring and screening of cognitive function in the ambulatory setting requires simple, brief cognitive tests that a..

Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.

Nathaniel Lizak, Charles B Malpas, Sifat Sharmin, Eva Kubala Havrdova, Dana Horakova, Guillermo Izquierdo, Sara Eichau, Alessandra Lugaresi, Pierre Duquette, Marc Girard, Alexandre Prat, Catherine Larochelle, Maria Trojano, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Diana Ferraro, Raymond Hupperts, Roberto Bergamaschi, Cavit Boz, et al.

Journal article  |  2020  |  JAMA Neurology

Importance: It is unclear whether relapses and disease-modifying therapies are associated with the rate of disability accumulation..

COVID-19 in people with multiple sclerosis: A global data sharing initiative

Liesbet M Peeters, Tina Parciak, Clare Walton, Lotte Geys, Yves Moreau, Edward De Brouwer, Daniele Raimondi, Ashkan Pirmani, Tomas Kalincik, Gilles Edan, Steve Simpson-Yap, Luc De Raedt, Yann Dauxais, Clement Gautrais, Paulo R Rodrigues, Landon McKenna, Nikola Lazovski, Jan Hillert, Lars Forsberg, Tim Spelman, et al.

Journal article  |  2020  |  Multiple Sclerosis Journal

BACKGROUND: We need high-quality data to assess the determinants for COVID-19 severity in people with MS (PwMS). Several studies h..

Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score

Amy Kunchok, Jeannette Lechner-Scott, Franco Granella, Maria Trojano, Raed Alroughani, Patrizia Sola, Diana Ferraro, Alessandra Lugaresi, Marco Onofrj, Serkan Ozakbas, Guillermo Izquierdo, Pierre Grammond, Jose Luis Sanchez-Menoyo, Bart Van Wijmeersch, Cavit Boz, Eugenio Pucci, Pamela McCombe, Francois Grand'Maison, Daniele Spitaleri, Steve Vucic, et al.

Journal article  |  2020  |  Multiple Sclerosis Journal

BACKGROUND: The magnetic resonance imaging in multiple sclerosis (MAGNIMS) score combines relapses and magnetic resonance imaging ..

Monitoring of radiologic disease activity by serum neurofilaments in MS

Tomas Uher, Sabine Schaedelin, Barbora Srpova, Christian Barro, Niels Bergsland, Michael Dwyer, Michaela Tyblova, Karolina Vodehnalova, Pascal Benkert, Johanna Oechtering, David Leppert, Yvonne Naegelin, Jan Krasensky, Manuela Vaneckova, Eva Kubala Havrdova, Ludwig Kappos, Robert Zivadinov, Dana Horakova, Jens Kuhle, Tomas Kalincik

Journal article  |  2020  |  Neurology, Neuroimmunology and Neuroinflammation

OBJECTIVE: To determine whether serum neurofilament light chain (sNfL) levels are associated with recent MRI activity in patients ..

Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

Le Minh, Charles Malpas, Sifat Sharmin, Dana Horakova, Eva Havrdova, Maria Trojano, Guillermo Izquierdo, Sara Eichau, Serkan Ozakbas, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Catherine Larochelle, Raed Alroughani, Roberto Bergamaschi, Patrizia Sola, Diana Ferraro, Pierre Grammond, Francois Grand' Maison, et al.

Journal article  |  2020  |  Multiple Sclerosis Journal

BACKGROUND: Cerebellar and brainstem symptoms are common in early stages of multiple sclerosis (MS) yet their prognostic values re..

Aggressive multiple sclerosis (2): Treatment.

Georgina Arrambide, Ellen Iacobaeus, Maria Pia Amato, Tobias Derfuss, Sandra Vukusic, Bernhard Hemmer, Lou Brundin, Mar Tintore, undefined 2018 ECTRIMS Focused Workshop Group

Journal article  |  2020  |  Multiple Sclerosis Journal

The natural history of multiple sclerosis (MS) is highly heterogeneous. A subgroup of patients has what might be termed aggressive..

Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy

Nathaniel Lizak, Suzanne Hodgkinson, Ernest Butler, Jeannette Lechner-Scott, Mark Slee, Pamela Ann McCombe, Cameron Shaw, Olga Skibina, Steve Vucic, Neil Shuey, Michael H Barnett, John Parratt, Helmut Butzkueven, Dominic Jack, Jessica Fabris, Tomas Kalincik

Journal article  |  2020  |  Multiple Sclerosis Journal

BACKGROUND/OBJECTIVE: Observational clinical data from cladribine-treated patients with relapsing forms of multiple sclerosis (MS)..

Aggressive multiple sclerosis (1): Towards a definition of the phenotype.

Ellen Iacobaeus, Georgina Arrambide, Maria Pia Amato, Tobias Derfuss, Sandra Vukusic, Bernhard Hemmer, Mar Tintore, Lou Brundin, undefined 2018 ECTRIMS Focused Workshop Group

Journal article  |  2020  |  Multiple Sclerosis Journal

While the major phenotypes of multiple sclerosis (MS) and relapsing-remitting, primary and secondary progressive MS have been well..

Early clinical markers of aggressive multiple sclerosis

Charles B Malpas, Ali Manouchehrinia, Sifat Sharmin, Izanne Roos, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Guillermo Izquierdo, Sara Eichau, Roberto Bergamaschi, Patrizia Sola, Diana Ferraro, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Francois Grand'Maison, Serkan Ozakbas, Vincent Van Pesch, et al.

Journal article  |  2020  |  Brain

Patients with the 'aggressive' form of multiple sclerosis accrue disability at an accelerated rate, typically reaching Expanded Di..

The histopathological staging of tau, but not amyloid, corresponds to antemortem cognitive status, dementia stage, functional abilities and neuropsychiatric symptoms

Charles B Malpas, Sifat Sharmin, Tomas Kalincik

Journal article  |  2020  |  International Journal of Neuroscience

Purpose: Alzheimer's disease (AD) is characterised by two cardinal pathologies, namely the extracellular accumulation amyloid-rela..

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

Anna He, Bernd Merkel, James William L Brown, Lana Zhovits Ryerson, Ilya Kister, Charles B Malpas, Sifat Sharmin, Dana Horakova, Eva Kubala Havrdova, Tim Spelman, Guillermo Izquierdo, Sara Eichau, Maria Trojano, Alessandra Lugaresi, Raymond Hupperts, Patrizia Sola, Diana Ferraro, Jan Lycke, Francois Grand'Maison, Alexandre Prat, et al.

Journal article  |  2020  |  The Lancet Neurology

BACKGROUND: High-efficacy therapies in multiple sclerosis are traditionally used after unsuccessful treatment with first-line dise..

Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial (vol 21, 100, 2020)

Litza Kiropoulos, Trevor Kilpatrick, Tomas Kalincik, Leonid Churilov, Elizabeth McDonald, Tissa Wijeratne, Jennifer Threader, Vanja Rozenblat, Neil O'Brien-Simpson, Anneke Van Der Walt, Lisa Taylor

Journal article  |  2020  |  Trials

After publication of our article [1] the authors have notified us that three of the names have been incorrectly spelled.

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG neuromyelitis optica spectrum disorder

Amy Kunchok, Charles Malpas, Petra Nytrova, Eva Kubala Havrdova, Raed Alroughani, Murat Terzi, Bassem Yamout, Jyh Yung Hor, Rana Karabudak, Cavit Boz, Serkan Ozakbas, Javier Olascoaga, Magdolna Simo, Franco Granella, Francesco Patti, Pamela McCombe, Tunde Csepany, Bhim Singhal, Roberto Bergamaschi, Yara Fragoso, et al.

Journal article  |  2020  |  Multiple Sclerosis and Related Disorders

BACKGROUND: Aquaporin-4-IgG positive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD) is an uncommon central nervous sys..

Presentation and outcome of patients with intracranial tuberculoma in a high HIV prevalence setting.

S Marais, I Roos, A Mitha, V Patel, T Kalincik, AI Bhigjee

Journal article  |  2020  |  The International Journal of Tuberculosis and Lung Disease

SETTING: A referral hospital in South Africa.OBJECTIVE: To describe the clinical presentation, serial brain imaging findings durin..

Psychometric properties of the Hospital Anxiety and Depression Scale in an inpatient video-monitoring epilepsy cohort

Lara McCartney, Benjamin Johnstone, Terence O'Brien, Patrick Kwan, Tomas Kalincik, Dennis Velakoulis, Charles Malpas

Journal article  |  2020  |  Epilepsy & Behavior

BACKGROUND: People with epilepsy (PWE) have high rates of comorbid anxiety disorders and depressive disorders, from 25% in general..

Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial

Litza Kiropoulos, Trevor Kilpatrick, Tomas Kalincek, Leonid Cherulov, Elizabeth McDonald, Tissa Wijeratne, Jennifer Threader, Vanja Rozenblat, Neil Simpson-O'Brien, Anneke Van der Walt, Lisa Taylor

Journal article  |  2020  |  Trials

BACKGROUND: Multiple sclerosis (MS) is an unpredictable, chronic neurological disease accompanied with high rates of depression an..

Distinct psychopathology profiles in patients with epileptic seizures compared to non-epileptic psychogenic seizures

Albert D Wang, Michelle Leong, Benjamin Johnstone, Genevieve Rayner, Tomas Kalincik, Izanne Roos, Patrick Kwan, Terence J O'Brien, Dennis Velakoulis, Charles B Malpas

Journal article  |  2019  |  Epilepsy Research

OBJECTIVE: Similarities in clinical presentations between epileptic seizures (ES) and psychogenic non-epileptic seizures (PNES) pr..

The MSBase registry: Informing clinical practice

Tomas Kalincik, Helmut Butzkueven

Journal article  |  2019  |  Multiple Sclerosis Journal

Over the last decade, clinical registries have significantly contributed to the pool of evidence that supports management decision..

Personality profiles differ between patients with epileptic seizures and patients with psychogenic non-epileptic seizures

Michelle Leong, Albert D Wang, David Trainor, Ben Johnstone, Genevieve Rayner, Tomas Kalincik, Izanne Roos, Patrick Kwan, Terence J O'Brien, Dennis Velakoulis, Charles B Malpas

Journal article  |  2019  |  Seizure

PURPOSE: Psychogenic non-epileptic seizures (PNES) and epileptic seizures (ES) are often difficult to differentiate, leading to in..

Abbreviated assessment of psychopathology in patients with suspected seizure disorders

Charles B Malpas, Albert D Wang, Michelle Leong, Benjamin Johnstone, Genevieve Rayner, Tomas Kalincik, Patrick Kwan, Terence J O'Brien, Dennis Velakoulis

Journal article  |  2019  |  Epilepsy & Behavior

PURPOSE: Psychopathology is common in patients undergoing investigation for seizure-related disorders. Psychometric examination us..

Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype

Yuan Zhou, Suzi B Claflin, Jim Stankovich, Ingrid van der Mei, Steve Simpson, Richard H Roxburgh, Tomas Kalincik, Leigh Blizzard, Alessandra Lugaresi, Raed Alroughani, Seyed Aidin Sajedi, Helmut Butzkueven, Eugenio Pucci, Daniele LA Spitaleri, Franco Granella, Edgardo Cristiano, Bassem Yamout, Stella Hughes, Riadh Gouider, Jose Luis Sanchez Menoyo, et al.

Journal article  |  2019  |  Multiple Sclerosis Journal

BACKGROUND: The Multiple Sclerosis Severity Score (MSSS) is a widely used measure of the disability progression rate. However, the..

Head-to-head drug comparisons in multiple sclerosis Urgent action needed

Carmen Tur, Tomas Kalincik, Jiwon Oh, Maria P Sormani, Mar Tintore, Helmut Butzkueven, Xavier Montalban

Journal article  |  2019  |  Neurology

Disease-modifying drugs are changing the natural history of multiple sclerosis (MS). However, currently available clinical trial d..

Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis

Daniel Ontaneda, Emma Tallantyre, Tomas Kalincik, Sarah M Planchon, Nikos Evangelou

Journal article  |  2019  |  The Lancet Neurology

PACS Integration of Semiautomated Imaging Software Improves Day-to-Day MS Disease Activity Detection

A Dahan, R Pereira, CB Malpas, T Kalincik, F Gaillard

Journal article  |  2019  |  American Journal of Neuroradiology

Real-world studies provide reliable comparisons of disease modifying therapies in MS - Yes

Tomas Kalincik

Journal article  |  2019  |  Multiple Sclerosis Journal

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination

Fiona Tea, Joseph A Lopez, Sudarshini Ramanathan, Vera Merheb, Fiona XZ Lee, Alicia Zou, Deepti Pilli, Ellis Patrick, Anneke van der Walt, Mastura Monif, Esther M Tantsis, Eppie M Yiu, Steve Vucic, Andrew PD Henderson, Anthony Fok, Clare L Fraser, Jeanette Lechner-Scott, Stephen W Reddel, Simon Broadley, Michael H Barnett, et al.

Journal article  |  2019  |  Acta Neuropathologica Communications

Immunotherapy prevents long-term disability in relapsing multiple sclerosis over 15 years

Tomas Kalincik, Sifat Sharmin, Charles Malpas, Tim Spelman, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Vilija Jokubaitis, Anneke van der Walt, Francois Grand’Maison, Patrizia Sola, Diana Ferraro, Vahid Shaygannejad, Raed Alroughani, et al.

Journal article  |  2019

ABSTRACT Objective Whether immunotherapy improves long-term disability in multiple sclerosis has not been satisfactorily demonstra..

Risk of secondary progressive multiple sclerosis: A longitudinal study

Adam Fambiatos, Vilija Jokubaitis, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Alexandre Prat, Marc Girard, Pierre Duquette, Alessandra Lugaresi, Guillermo Izquierdo, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Diana Ferraro, Raed Alroughani, Murat Terzi, Raymond Hupperts, Cavit Boz, Jeannette Lechner-Scott, Eugenio Pucci, et al.

Journal article  |  2019  |  Multiple Sclerosis Journal

Personality profiles differ between patients with epileptic seizures and patients with psychogenic non-epileptic seizures

Michelle Leong, Albert Wang, David Trainor, Benjamin Johnstone, Genevieve Rayner, Tomas Kalincik, Patrick Kwan, Terence O'Brien, Dennis Velakoulis, Charles Malpas

Journal article  |  2019

Aim: The primary aim of the study was to determine whether patients with psychogenic non-epileptic seizures (PNES) have different ..

Early clinical markers of aggressive multiple sclerosis

Charles Malpas, Ali Ali Manouchehrinia, Sifat Sharmin, Izanne Roos, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Guillermo Izquierdo, Sara Eichau, Roberto Bergamaschi, Patrizia Sola, Diana Ferraro, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Francois Grand'Maison, Serkan Ozakbas, Vincent Van Pesch, et al.

Journal article  |  2019

Patients with the 'aggressive' form of MS accrue disability at an accelerated rate, typically reaching EDSS >= 6 within 10 years o..

The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis

Daniel Merlo, David Darby, Tomas Kalincik, Helmut Butzkueven, Anneke van der Walt

Journal article  |  2019  |  Therapeutic Advances in Neurological Disorders

Background: Multiple sclerosis (MS) cognitive tests are resource intensive and limited by practice effects that prevent frequent r..

The histopathological staging of tau, but not amyloid, corresponds to antemortem cognitive status, dementia stage, functional abilities, and neuropsychiatric symptoms

Charles Malpas, Sifat Sharmin, Tomas Kalincik

Journal article  |  2019

Abstract Objective Alzheimer’s disease (AD) is characterised by two cardinal pathologies, namely the extracellular accumulation am..

Effectiveness of oral multiple sclerosis therapies in clinical context

Tomas Kalincik

Journal article  |  2019  |  Neurology

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

Tomas Kalincik, Eva Kubala Havrdova, Dana Horakova, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Marco Onofrj, Alessandra Lugaresi, Serkan Ozakbas, Ludwig Kappos, Jens Kuhle, Murat Terzi, Jeannette Lechner-Scott, Cavit Boz, Francois Grand'Maison, Julie Prevost, Patrizia Sola, Diana Ferraro, et al.

Journal article  |  2019  |  Journal of Neurology, Neurosurgery & Psychiatry

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

Ai-Lan Nguyen, Eva Kubala Havrdova, Dana Horakova, Guillermo Izquierdo, Tomas Kalincik, Anneke van der Walt, Murat Terzi, Raed Alroughani, Pierre Duquette, Marc Girard, Alexandre Prat, Cavit Boz, Patrizia Sola, Diana Ferrara, Alessandra Lugaresi, Jeannette Lechner-Scott, Michael Barnett, Francois Grand'Maison, Pierre Grammond, Cristina Ramo-Tello, et al.

Journal article  |  2019  |  Multiple Sclerosis and Related Disorders

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horakova, Eva Havrdova, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Maria Trojano, Alessandra Lugaresi, Roberto Bergamaschi, Pierre Grammond, Raed Alroughani, Raymond Hupperts, Pamela McCombe, Vincent Van Pesch, Patrizia Sola, Diana Ferraro, Francois Grand'Maison, Murat Terzi, et al.

Journal article  |  2019  |  JAMA

Where there is inflammation, treatment may reduce disability progression - Yes

Tomas Kalincik

Journal article  |  2018  |  Multiple Sclerosis Journal

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis

Jordana Hughes, Vilija Jokubaitis, Alessandra Lugaresi, Raymond Hupperts, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Diana Ferraro, Cristina Ramo-Tello, Maria Trojan, Mark Slee, Vahid Shaygannejad, Cavit Boz, Jeanette Lechner-Scott, Vincent Van Pesch, Eugenio Pucci, et al.

Journal article  |  2018  |  JAMA Neurology

Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis

Myintzu Min, Tim Spelman, Alessandra Lugaresi, Cavit Boz, Daniele LA Spitaleri, Eugenio Pucci, Francois Grand'Maison, Franco Granella, Guillermo Izquierdo, Helmut Butzkueven, Jose Luis Sanchez-Menoyo, Michael Barnett, Marc Girard, Maria Trojano, Pierre Grammond, Pierre Duquette, Patrizia Sola, Raed Alroughani, Raymond Hupperts, Steve Vucic, et al.

Journal article  |  2018  |  Multiple Sclerosis Journal

Cladribine versus fingolimod, natalizumab and interferon for multiple sclerosis

Tomas Kalincik, Vilija Jokubaitis, Tim Spelman, Dana Horakova, Eva Havrdova, Maria Trojano, Jeannette Lechner-Scott, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Claudio Solaro, Francois Grand'Maison, Raymond Hupperts, Julie Prevost, Patrizia Sola, Diana Ferraro, Murat Terzi, Ernest Butler, et al.

Journal article  |  2018  |  MULTIPLE SCLEROSIS JOURNAL

Comparisons of therapies in different scenarios help complete the puzzle

Tomas Kalincik

Journal article  |  2018  |  Multiple Sclerosis Journal

Reply: Towards personalized therapy for multiple sclerosis: limitations of observational data

Tomas Kalincik

Journal article  |  2018  |  Brain

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Alessio Signori, Guillermo Izquierdo, Alessandra Lugaresi, Raymond Hupperts, Francois Grand'Maison, Patrizia Sola, Dana Horakova, Eva Havrdova, Alexandre Prat, Marc Girard, Pierre Duquette, Cavit Boz, Pierre Grammond, Murat Terzi, Bhim Singhal, Raed Alroughani, Thor Petersen, Cristina Ramo, Celia Oreja-Guevara, Daniele Spitaleri, et al.

Journal article  |  2018  |  MULTIPLE SCLEROSIS JOURNAL

Cognitive clinico-radiological paradox in early stages of multiple sclerosis

Tomas Uher, Jan Krasensky, Lukas Sobisek, Jana Blahova Dusankova, Zdenek Seidl, Eva Kubala Havrdova, Maria Pia Sormani, Dana Horakova, Tomas Kalincik, Manuela Vaneckova

Journal article  |  2018  |  Annals of Clinical and Translational Neurology

Factors that affect computerized cognitive screening in people with MS: diurnal variation, location and practice effects

D Merlo, A Van der Walt, J Haartsen, T Kalincik, H Butzkueven, D Darby

Artefact  |  2017  |  Multiple Sclerosis Journal

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS

Johannes Lorscheider, Vilija G Jokubaitis, Tim Spelman, Guillermo Izquierdo, Alessandra Lugaresi, Eva Havrdova, Dana Horakova, Maria Trojano, Pierre Duquette, Marc Girard, Alexandre Prat, Francois Grand'Maison, Pierre Grammond, Eugenio Pucci, Cavit Boz, Patrizia Sola, Diana Ferraro, Daniele Spitaleri, Jeanette Lechner-Scott, Murat Terzi, et al.

Journal article  |  2017  |  NEUROLOGY

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice

Tim Spelman, Claire Meyniel, Juan Ignacio Rojas, Alessandra Lugaresi, Guillermo Izquierdo, Francois Grand'Maison, Cavit Boz, Raed Alroughani, Eva Havrdova, Dana Horakova, Gerardo Iuliano, Pierre Duquette, Murat Terzi, Pierre Grammond, Raymond Hupperts, Jeannette Lechner-Scott, Celia Oreja-Guevara, Eugenio Pucci, Freek Verheul, Marcela Fiol, et al.

Journal article  |  2017  |  MULTIPLE SCLEROSIS JOURNAL

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response

Tomas Kalincik, Ali Manouchehrinia, Lukas Sobisek, Vilija Jokubaitis, Tim Spelman, Dana Horakova, Eva Havrdova, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Marc Girard, Alexandre Prat, Pierre Duquette, Pierre Grammond, Patrizia Sola, Raymond Hupperts, Francois Grand'Maison, Eugenio Pucci, Cavit Boz, Raed Alroughani, et al.

Journal article  |  2017  |  BRAIN

Stop inflammation and you stop neurodegeneration in MS - NO

Tomas Kalincik

Journal article  |  2017  |  MULTIPLE SCLEROSIS JOURNAL

Familial Mesial Temporal Lobe Epilepsy and the Borderland of Deja Vu

Piero Perucca, Douglas E Crompton, Susannah T Bellows, Anne M McIntosh, Tomas Kalincik, Mark R Newton, Frank JE Vajda, Ingrid E Scheffer, Patrick Kwan, Terence J O'Brien, K Meng Tan, Samuel F Berkovic

Journal article  |  2017  |  ANNALS OF NEUROLOGY

Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: A systematic review

Bernd Merkel, Helmut Butzkueven, Anthony L Traboulsee, Eva Havrdova, Tomas Kalincik

Journal article  |  2017  |  AUTOIMMUNITY REVIEWS

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

Tomas Kalincik, J William L Brown, Neil Robertson, Mark Willis, Neil Scolding, Claire M Rice, Alastair Wilkins, Owen Pearson, Tjalf Ziemssen, Michael Hutchinson, Christopher McGuigan, Vilija Jokubaitis, Tim Spelman, Dana Horakova, Eva Havrdova, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Alexandre Prat, Marc Girard, et al.

Journal article  |  2017  |  LANCET NEUROLOGY

Data quality evaluation for observational multiple sclerosis registries

Tomas Kalincik, Jens Kuhle, Eugenio Pucci, Juan Ignacio Rojas, Magda Tsolaki, Carmen-Adella Sirbu, Mark Slee, Helmut Butzkueven

Journal article  |  2017  |  MULTIPLE SCLEROSIS JOURNAL

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Nathaniel Lizak, Alessandra Lugaresi, Raed Alroughani, Jeannette Lechner-Scott, Mark Slee, Eva Havrdova, Dana Horakova, Maria Trojano, Guillermo Izquierdo, Pierre Duquette, Marc Girard, Alexandre Prat, Pierre Grammond, Raymond Hupperts, Francois Grand'Maison, Patrizia Sola, Eugenio Pucci, Roberto Bergamaschi, Celia Oreja-Guevara, Vincent Van Pesch, et al.

Journal article  |  2017  |  JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Treatment decisions in multiple sclerosis - insights from real-world observational studies

Maria Trojano, Mar Tintore, Xavier Montalban, Jan Hillert, Tomas Kalincik, Pietro Laffaldano, Tim Spelman, Maria Pia Sormani, Helmut Butzkueven

Journal article  |  2017  |  Nature Reviews Neurology

Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach

T Uher, M Vaneckova, MP Sormani, J Krasensky, L Sobisek, J Blahova Dusankova, Z Seidl, E Havrdova, T Kalincik, RHB Benedict, D Horakova

Journal article  |  2017  |  EUROPEAN JOURNAL OF NEUROLOGY

Contribution of different relapse phenotypes to disability in multiple sclerosis

Tamasine Stewart, Tim Spelman, Eva Havrdova, Dana Horakova, Maria Trojano, Guillermo Izquierdo, Pierre Duquette, Marc Girard, Alexandre Prat, Alessandra Lugaresi, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Vahid Shaygannejad, Raymond Hupperts, Raed Alroughani, Celia Oreja-Guevara, Eugenio Pucci, Cavit Boz, Jeannette Lechner-Scott, et al.

Journal article  |  2017  |  MULTIPLE SCLEROSIS JOURNAL

Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis

Tomas Uher, Manuela Vaneckova, Lukas Sobisek, Michaela Tyblova, Zdenek Seidl, Jan Krasensky, Deepa Ramasamy, Robert Zivadinov, Eva Havrdova, Tomas Kalincik, Dana Horakova

Journal article  |  2017  |  Multiple Sclerosis Journal

Reporting treatment outcomes in observational data: A fine balance

Tomas Kalincik, Maria Pia Sormani

Journal article  |  2017  |  Multiple Sclerosis Journal

Olfactory ensheathing cells but not fibroblasts reduce the duration of autonomic dysreflexia in spinal cord injured rats

Frank Cloutier, Tomas Kalincik, Jenny Lauschke, Gervase Tuxworth, Brenton Cavanagh, Adrian Meedeniya, Alan Mackay-Sim, Pascal Carrive, Phil Waite

Journal article  |  2016  |  AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Impairment of Smooth Pursuit as a Marker of Early Multiple Sclerosis

Nathaniel Lizak, Meaghan Clough, Lynette Millist, Tomas Kalincik, Owen B White, Joanne Fielding

Journal article  |  2016  |  FRONTIERS IN NEUROLOGY

Observational data: Understanding the real MS world

Tomas Kalincik, Helmut Butzkueven

Journal article  |  2016  |  Multiple Sclerosis Journal

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

N Lizak, A Lugaresi, R Alroughani, J Lechner-Scott, M Slee, E Havrdova, D Horakova, M Trojano, G Izquierdo, P Duquette, M Girard, A Prat, P Grammond, R Hupperts, FG Maison, P Sola, E Pucci, R Bergamaschi, C Oreja-Guevara, VV Pesch, et al.

Journal article  |  2016  |  Journal of Neurology, Neurosurgery and Psychiatry

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis, Tim Spelman, Eva Havrdova, Dana Horakova, Maria Trojano, Guillermo Izquierdo, Marc Girard, Pierre Duquette, Alexandre Prat, Alessandra Lugaresi, Francois Grand'Maison, Pierre Grammond, Raymond Hupperts, Raed Alroughani, Patrizia Sola, Cavit Boz, Eugenio Pucci, Jeanette Lechner-Scott, et al.

Journal article  |  2016  |  BRAIN

Anti-inflammatory disease modifying treatment does not attenuate disability progression in secondary progressive multiple sclerosis

J Lorscheider, V Jokubaitis, T Spelman, G Izquierdo, A Lugaresi, E Havrdova, D Horakova, M Trojano, P Duquette, M Girard, A Prat, F Grand'Maison, R Hupperts, P Grammond, E Pucci, C Boz, P Sola, D Spitaleri, J Lechner-Scott, M Terzi, et al.

Conference Proceedings  |  2016  |  MULTIPLE SCLEROSIS JOURNAL

Pregnancy protects against long-term disability accrual in relapsing-remitting MS

VG Jokubaitis, T Kalincik, J Lorscheider, T Spelman, D Horakova, P Duquette, M Girard, A Prat, G Izquierdo, P Grammond, E Pucci, F Grand'Maison, F Granella, P Sola, R Bergamaschi, G Iuliano, D Spitaleri, S Hodgkinson, J Olascoaga, F Verheul, et al.

Conference Proceedings  |  2016  |  MULTIPLE SCLEROSIS JOURNAL

Predictors of Long-Term Disability Accrual in Relapse-Onset Multiple Sclerosis

Vilija G Jokubaitis, Tim Spelman, Tomas Kalincik, Johannes Lorscheider, Eva Havrdova, Dana Horakova, Pierre Duquette, Marc Girard, Alexandre Prat, Guillermo Izquierdo, Pierre Grammond, Vincent Van Pesch, Eugenio Pucci, Francois Grand'Maison, Raymond Hupperts, Franco Granella, Patrizia Sola, Roberto Bergamaschi, Gerardo Iuliano, Daniele Spitaleri, et al.

Journal article  |  2016  |  Annals of Neurology

Identification of MS patients at highest risk of cognitive impairment using integrated brain MRI assessment approach

T Uher, M Vaneckova, MP Sormani, J Krasensky, L Sobisek, J Blahova, Z Seidl, E Havrdova, T Kalincik, RH Benedict, D Horakova

Conference Proceedings  |  2016  |  EUROPEAN JOURNAL OF NEUROLOGY

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

Matthew Warrender-Sparkes, Tim Spelman, Guillermo Izquierdo, Maria Trojano, Alessandra Lugaresi, Francois Grand'Maison, Eva Havrdova, Dana Horakova, Cavit Boz, Celia Oreja-Guevara, Raed Alroughani, Gerardo Iuliano, Pierre Duquette, Marc Girard, Murat Terzi, Raymond Hupperts, Pierre Grammond, Thor Petersen, Ricardo Fernandez-Bolanos, Marcela Fiol, et al.

Journal article  |  2016  |  MULTIPLE SCLEROSIS JOURNAL

Comparative efficacy of first-line natalizumab vs IFN-beta or glatiramer acetate in relapsing MS

Tim Spelman, Tomas Kalincik, Vilija Jokubaitis, Annie Zhang, Fabio Pellegrini, Heinz Wiendl, Shibeshih Belachew, Robert Hyde, Freek Verheul, Alessandra Lugaresi, Eva Havrdova, Dana Horakova, Pierre Grammond, Pierre Duquette, Alexandre Prat, Gerardo Iuliano, Murat Terzi, Guillermo Izquierdo, Raymond MM Hupperts, Cavit Boz, et al.

Journal article  |  2016  |  Neurology: Clinical Practice

Efficacy and Treatment Persistence of First-line Natalizumab vs. Interferon beta or Glatiramer Acetate in relapsing MS.

H Butzkueven, T Spelman, T Kalincik, V Jokubaitis, A Zhang, F Pellegrini, H Wiendl, S Belachew, R Hyde, F Verheul, A Lugaresi, E Havrdova, D Horakova, P Grammond, P Duquette, A Prat, G Iuliano, M Terzi, G Izquierdo, R Hupperts, et al.

Conference Proceedings  |  2016  |  MULTIPLE SCLEROSIS JOURNAL

First-line injectable therapy and pregnancy protect against long-term disability accrual in patients with relapse-onset multiple sclerosis

Vilija Jokubaitis, Tim Spelman, Tomask Kalincik, Johannes Lorscheider, Pamela McCombe, Jeannette Lechner-Scott, Suzanne Hodgkinson, Helmut Butzkueven

Conference Proceedings  |  2015  |  MULTIPLE SCLEROSIS JOURNAL

Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis

Nathaniel Lizak, Alessandra Lugaresi, Raed Alroughani, Jeannette Lechner-Scott, Mark Slee, Suzanne Hodgkinson, Vilija Jokubaitis, Tim Spelman, Helmut Butzkueven, Tomas Kalincik

Conference Proceedings  |  2015  |  MULTIPLE SCLEROSIS JOURNAL

Defining reliable disability outcomes in multiple sclerosis

Tomas Kalincik, Gary Cutter, Tim Spelman, Vilija Jokubaitis, Eva Havrdova, Dana Horakova, Maria Trojano, Guillermo Izquierdo, Marc Girard, Pierre Duquette, Alexandre Prat, Alessandra Lugaresi, Francois Grand'Maison, Pierre Grammond, Raymond Hupperts, Celia Oreja-Guevara, Cavit Boz, Eugenio Pucci, Roberto Bergamaschi, Jeannette Lechner-Scott, et al.

Journal article  |  2015  |  BRAIN

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Tomas Kalincik, Vilija Jokubaitis, Guillermo Izquierdo, Pierre Duquette, Marc Girard, Pierre Grammond, Alessandra Lugaresi, Celia Oreja-Guevara, Roberto Bergamaschi, Raymond Hupperts, Francois Grand'Maison, Eugenio Pucci, Vincent Van Pesch, Cavit Boz, Gerardo Iuliano, Ricardo Fernandez-Bolanos, Shlomo Flechter, Daniele Spitaleri, Edgardo Cristiano, Freek Verheul, et al.

Journal article  |  2015  |  MULTIPLE SCLEROSIS JOURNAL

Early magnetic resonance imaging predictors of clinical progression after 48months in clinically isolated syndrome patients treated with intramuscular interferon beta-1a

T Uher, D Horakova, T Kalincik, N Bergsland, M Tyblova, DP Ramasamy, Z Seidl, M Vaneckova, J Krasensky, E Havrdova, R Zivadinov

Journal article  |  2015  |  European Journal of Neurology

Predictors of disability worsening in clinically isolated syndrome

Vilija G Jokubaitis, Tim Spelman, Tomas Kalincik, Guillermo Izquierdo, Francois Grand'Maison, Pierre Duquette, Marc Girard, Alessandra Lugaresi, Pierre Grammond, Raymond Hupperts, Jose Cabrera-Gomez, Celia Oreja-Guevara, Cavit Boz, Giorgio Giuliani, Ricardo Fernandez-Bolanos, Gerardo Iuliano, Jeannette Lechner-Scott, Freek Verheul, Vincent van Pesch, Tatjana Petkovska-Boskova, et al.

Journal article  |  2015  |  ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY

Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis

M Tyblova, T Kalincik, V Zikan, E Havrdova

Journal article  |  2015  |  EUROPEAN JOURNAL OF NEUROLOGY

Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis

Anna He, Tim Spelman, Vilija Jokubaitis, Eva Havrdova, Dana Horakova, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Marc Girard, Eugenio Pucci, Gerardo Iuliano, Raed Alroughani, Celia Oreja-Guevara, Ricardo Fernandez-Bolanos, Francois Grand'Maison, Patrizia Sola, Daniele Spitaleri, Franco Granella, et al.

Journal article  |  2015  |  JAMA NEUROLOGY

Comparative efficacy of switching to natalizumab in active multiple sclerosis

Timothy Spelman, Tomas Kalincik, Annie Zhang, Fabio Pellegrini, Heinz Wiendl, Ludwig Kappos, Larisa Tsvetkova, Shibeshih Belachew, Robert Hyde, Freek Verheul, Francois Grand-Maison, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Alessandra Lugaresi, Jeannette Lechner-Scott, Celia Oreja-Guevara, Raymond Hupperts, Thor Petersen, Michael Barnett, et al.

Journal article  |  2015  |  ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY

Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis

Tomas Kalincik, Dana Horakova, Tim Spelman, Vilija Jokubaitis, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Csilla Rozsa, Pierre Grammond, Raed Alroughani, Pierre Duquette, Marc Girard, Eugenio Pucci, Jeannette Lechner-Scott, Mark Slee, Ricardo Fernandez-Bolanos, Francois Grand'Maison, Raymond Hupperts, Freek Verheul, Suzanne Hodgkinson, et al.

Journal article  |  2015  |  ANNALS OF NEUROLOGY

Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review

Tomas Kalincik

Journal article  |  2015  |  NEUROEPIDEMIOLOGY

Risk of relapse phenotype recurrence in multiple sclerosis

Tomas Kalincik, Katherine Buzzard, Vilija Jokubaitis, Maria Trojano, Pierre Duquette, Guillermo Izquierdo, Marc Girard, Alessandra Lugaresi, Pierre Grammond, Francois Grand'Maison, Celia Oreja-Guevara, Cavit Boz, Raymond Hupperts, Thor Petersen, Giorgio Giuliani, Gerardo Iuliano, Jeannette Lechner-Scott, Michael Barnett, Roberto Bergamaschi, Vincent Van Pesch, et al.

Journal article  |  2014  |  MULTIPLE SCLEROSIS JOURNAL

Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome

Tomas Uher, Jana Blahova-Dusankova, Dana Horakova, Niels Bergsland, Michaela Tyblova, Ralph HB Benedict, Tomas Kalincik, Deepa P Ramasamy, Zdenek Seidl, Jesper Hagermeier, Manuela Vaneckova, Jan Krasensky, Eva Havrdova, Robert Zivadinov

Journal article  |  2014  |  Journal of Neurology

After a relapse, patients who switch to natalizumab have better outcomes than those who switch between platform therapies

M Trojano, T Spelman, T Kalincik, A Zhang, H Wiendl, L Kappos, S Belachew, R Hyde, F Verheul, F Grand-Maison, G Izquierdo, H Butzkueven

Conference Proceedings  |  2014  |  EUROPEAN JOURNAL OF NEUROLOGY

Fingolimod after natalizumab and the risk of short-term relapse

Vilija G Jokubaitis, Vivien Li, Tomas Kalincik, Guillermo Izquierdo, Suzanne Hodgkinson, Raed Alroughani, Jeannette Lechner-Scott, Alessandra Lugaresi, Pierre Duquette, Marc Girard, Michael Barnett, Francois Grand'Maison, Maria Trojano, Mark Slee, Giorgio Giuliani, Cameron Shaw, Cavit Boz, Daniele LA Spitaleri, Freek Verheul, Jodi Haartsen, et al.

Journal article  |  2014  |  NEUROLOGY

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Tomas Kalincik, Vino Vivek, Vilija Jokubaitis, Jeannette Lechner-Scott, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Francois Grand'Maison, Raymond Hupperts, Celia Oreja-Guevara, Roberto Bergamaschi, Gerardo Iuliano, Raed Alroughani, Vincent Van Pesch, Maria Pia Amato, Mark Slee, Freek Verheul, Ricardo Fernandez-Bolanos, Marcela Fiol, Daniele La Spitaleri, et al.

Journal article  |  2013  |  BRAIN

Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years

R Zivadinov, N Bergsland, O Dolezal, S Hussein, Z Seidl, MG Dwyer, M Vaneckova, J Krasensky, JA Potts, T Kalincik, E Havrdova, D Horakova

Journal article  |  2013  |  American Journal of Neuroradiology

Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome

T Kalincik, CRG Guttmann, J Krasensky, M Vaneckova, P Lelkova, M Tyblova, Z Seidl, PL De Jager, E Havrdova, D Horakova

Journal article  |  2013  |  Genes and Immunity

Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome

T Kalincik, CRG Guttmann, J Krasensky, M Vaneckova, P Lelkova, M Tyblova, Z Seidl, PL De Jager, E Havrdova, D Horakova

Journal article  |  2013  |  Genes and Immunity

Thalamic Atrophy Is Associated with Development of Clinically Definite MS

Robert Zivadinov, Eva Havrdova, Niels Bergsland, Michaela Tyblova, Jesper Hagemeier, Zdenek Seidl, Michael Dwyer, Manuela Vaneckova, Jan Krasensky, Ellen Carl, Tomas Kalincik, Dana Horakova

Journal article  |  2013  |  Radiology

Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study

Dana Horakova, Robert Zivadinov, Bianca Weinstock-Guttman, Eva Havrdova, Jun Qu, Miriam Tamano-Blanco, Darlene Badgett, Michaela Tyblova, Niels Bergsland, Sara Hussein, Laura Willis, Jan Krasensky, Manuela Vaneckova, Zdenek Seidl, Petra Lelkova, Michael G Dwyer, Ming Zhang, Haoying Yu, Xiaotao Duan, Tomas Kalincik, et al.

Journal article  |  2013  |  PLoS One

Late-onset Tay-Sachs Disease Can Mimic Spinal Muscular Atrophy Type III - Two Case Reports

I Prihodova, T Kalincik, H Poupetova, H Jahnova, S Nevsimalova

Journal article  |  2013  |  Ceska a Slovenska Neurologie a Neurochirurgie

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis.

Tomas Kalincik, Timothy Spelman, Maria Trojano, Pierre Duquette, Guillermo Izquierdo, Pierre Grammond, Alessandra Lugaresi, Raymond Hupperts, Edgardo Cristiano, Vincent Van Pesch, Francois Grand'maison, Daniele La Spitaleri, Maria Edite Rio, Sholmo Flechter, Celia Oreja-Guevara, Giorgio Giuliani, Aldo Savino, Maria Pia Amato, Thor Petersen, Ricardo Fernandez-Bolanos, et al.

Journal article  |  2013  |  PLoS One

OBJECTIVES: To compare treatment persistence between two dosages of interferon β-1a in a large observational multiple sclerosis re..

Early predictors of non-response to interferon in multiple sclerosis

D Horakova, T Kalincik, O Dolezal, J Krasensky, M Vaneckova, Z Seidl, E Havrdova

Journal article  |  2012  |  Acta Neurologica Scandinavica

Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis

Veronika Ticha, Tomas Kalincik, Eva Havrdova

Journal article  |  2012  |  Neurological Research

Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study

Tomas Kalincik, Manuela Vaneckova, Michaela Tyblova, Jan Krasensky, Zdenek Seidl, Eva Havrdova, Dana Horakova

Journal article  |  2012  |  PLoS One

Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort

T Kalincik, D Horakova, O Dolezal, J Krasensky, M Vaneckova, Z Seidl, E Havrdova

Journal article  |  2012  |  Clinical Neurology and Neurosurgery

Cost of multiple sclerosis in the Czech Republic: The COMS study

J Blahova Dusankova, T Kalincik, T Dolezal, G Kobelt, E Havrdova

Journal article  |  2012  |  Multiple Sclerosis

Clinical correlates of grey matter pathology in multiple sclerosis

Dana Horakova, Tomas Kalincik, Jana Blahova Dusankova, Ondrej Dolezal

Journal article  |  2012  |  BMC Neurology

Disturbance of real space navigation in moderately advanced but not in early Huntington's disease

Veronika Majerova, Tomas Kalincik, Jan Laczo, Martin Vyhnalek, Jakub Hort, Martin Bojar, Evzen Ruzicka, Jan Roth

Journal article  |  2012  |  Journal of the Neurological Sciences

Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study

M Vaneckova, T Kalincik, J Krasensky, D Horakova, E Havrdova, T Hrebikova, Z Seidl

Journal article  |  2012  |  European Neurology

Cross Cultural Validation of The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

Jana Blahova Dusankova, Tomas Kalincik, Eva Havrdova, Ralph HB Benedict

Journal article  |  2012  |  Clinical Neuropsychologist

Microsatellite Polymorphism in Haem Oxygenase 1 Gene Promoter in Multiple Sclerosis

P Zbornikova, L Kralik, P Lelkova, T Kalincik, E Havrdova, P Martasek

Journal article  |  2012  |  Folia Neuropathologica

Interferon beta or azathioprine as add-on therapies in patients with active multiple sclerosis

V Ticha, T Kalincik, E Havrdova

Journal article  |  2012  |  Neurological Research

Interferon-beta or azathioprine as add-on therapy in patients with active multiple sclerosis

V Ticha, T Kalincik, E Havrdova

Conference Proceedings  |  2011  |  MULTIPLE SCLEROSIS JOURNAL

Selected changes in spinal cord morphology after T4 transection and olfactory ensheathing cell transplantation

Tomas Kalincik, Katarina Jozefcikova, Ratneswary Sutharsan, Alan Mackay-Sim, Pascal Carrive, Phil ME Waite

Journal article  |  2010  |  Autonomic Neuroscience - Basic & Clinical

Arteriovenous differences of hematological and coagulation parameters in patients with sepsis

Miroslav Durila, Tomas Kalincik, Sergej Jurcenko, Martina Pelichovska, Ivana Hadacova, Karel Cvachovec

Journal article  |  2010  |  Blood Coagulation and Fibrinolysis

Heparinase-modified thromboelastography can result in a fibrinolytic pattern

M Durila, T Kalincik, K Cvachovec, R Filho

Journal article  |  2010  |  Anaesthesia

Olfactory ensheathing cells reduce duration of autonomic dysreflexia in rats with high spinal cord injury

Tomas Kalincik, Eun A Choi, Francois Feron, John Bianco, Ratneswary Sutharsan, Ian Hayward, Alan Mackay-Sim, Pascal Carrive, Phil ME Waite

Journal article  |  2010  |  Autonomic Neuroscience - Basic & Clinical

Discard volume necessary for elimination of heparin flush effect on thromboelastography

Miroslav Durila, Tomas Kalincik, Zuzana Pacakova, Karel Cvachovec

Journal article  |  2010  |  Blood Coagulation and Fibrinolysis

Local response to cold in rat tail after spinal cord transection

Tomas Kalincik, Katarina Jozefcikova, Phil ME Waite, Pascal Carrive

Journal article  |  2009  |  Journal of Applied Physiology

Influence of magnesium sulphate on evoked activity of rat brain after exposure to short-term hypoxia

T Kalincik, D Maresova

Journal article  |  2005  |  Physiological Research